Home > Insider Trading > Filing (0001567619-19-002400)

Filing Details

Accession Number:: 0001567619-19-002400
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-02-05 17:35:50
Reporting Period:: 2019-02-01

Accepted Time:: 2019-02-05 17:35:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1561387	Health Insurance Innovations Inc.	HIIQ	Insurance Agents, Brokers & Service (6411)	461282634

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1678010	Gavin Southwell	C/O Health Insurance Innovations, Inc. 15438 North Florida Ave., Suite 201 Tampa FL 33613	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Disposition	2019-02-01	6,150	$40.02	609,723	No	4	S	Direct
Class A Common Stock	Disposition	2019-02-04	65,899	$40.31	543,824	No	4	S	Direct
Class A Common Stock	Disposition	2019-04-05	7,647	$40.03	536,177	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Class A Common Stock	Stock Appreciation Rights	$6.10	2023-04-26	20,000	20,000	Direct
Class A Common Stock	Stock Appreciation Rights	$5.96	2023-09-06	33,333	33,333	Direct
Class A Common Stock	Stock Appreciation Rights	$10.30	2023-11-15	100,000	100,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2023-04-26	20,000	20,000	Direct
2023-09-06	33,333	33,333	Direct
2023-11-15	100,000	100,000	Direct

Footnotes

Sales made pursuant to a 10b5-1 plan previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.22, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations, Inc. (the "Company), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Sales made pursuant to a 10b5-1 plan previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $41.58, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations, Inc. (the "Company), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Sales made pursuant to a 10b5-1 plan previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.08, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations, Inc. (the "Company), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
These stock-settled stock appreciation rights were granted under the Plan and vest 50% on the first anniversary of grant date and 50% on the second anniversary of grant date, subject to the terms of the Plan and an award agreement under the Plan.
These stock-settled stock appreciation rights were granted under the Plan and vest 25% on the first anniversary of grant date, 25% on the second anniversary of grant date, and 50% on the third anniversary of grant date, subject to the terms of the Plan and an award agreement under the Plan.
These stock-settled stock appreciation rights were granted under the Plan and vest 25% on each of the first four anniversaries of the date of grant, subject to the terms of the Plan and an award agreement under the Plan.